- Home
- ZYME vs BWIN Comparison
ZYME vs BWIN Comparison
Compare ZYME & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZYME | BWIN |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZYME | BWIN |
|---|---|---|
| Price | $22.83 | $25.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | $32.75 | ★ $34.00 |
| AVG Volume (30 Days) | 900.1K | ★ 1.1M |
| Earning Date | 03-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $134,481,000.00 | ★ $1,487,497,000.00 |
| Revenue This Year | $64.19 | $10.94 |
| Revenue Next Year | $91.98 | $27.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 116.21 | 10.69 |
| 52 Week Low | $9.03 | $21.26 |
| 52 Week High | $28.49 | $47.15 |
Technical Indicators
Market Signals| Indicator | ZYME | BWIN |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 51.59 |
| Support Level | $22.80 | $24.89 |
| Resistance Level | $24.31 | $26.82 |
| Average True Range (ATR) | 1.16 | 1.23 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 18.51 | 61.43 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About BWIN The Baldwin Insurance Group Inc.
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.